Drug
SAR425899 clinical trials
Also written SAR425899.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SAR425899 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsCompletedPhase 1SanofiNCT03350191Written as SAR425899
- A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension PeriodCompletedPhase 1SanofiNCT03414736Written as SAR425899
- A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese SubjectsCompletedPhase 1SanofiNCT03376802Written as SAR425899
- Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver DiseaseWithdrawnPhase 2SanofiNCT03437720Written as SAR425899
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusCompletedPhase 2SanofiNCT02973321Written as SAR425899
- Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCompletedPhase 1SanofiNCT02411825Written as SAR425899